In addition, cutaneous leishmaniasis is also characterized by vascular remodeling and lymphangiogenesis mediated by the vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 (VEGFR-2) signaling pathway that is essential for lesion resolution (71, 101, 102). This evidence concerns the gene KDR and cutaneous leishmaniasis.